These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 34087613)

  • 1. Does COVID 19 generate a milieu for propagation of mucormycosis?
    Pandiar D; Kumar NS; Anand R; Kamboj M; Narwal A; Shameena PM
    Med Hypotheses; 2021 Jul; 152():110613. PubMed ID: 34087613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
    Lugito NPH; Cucunawangsih C
    Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.
    Dave TV; Nair AG; Joseph J; Freitag SK
    Orbit; 2022 Dec; 41(6):670-679. PubMed ID: 35856238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19.
    Dwivedi S; Choudhary P; Gupta A; Singh S
    Crit Rev Microbiol; 2023 May; 49(3):318-333. PubMed ID: 35324372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
    Gurunathan S; Lee AR; Kim JH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID19 associated mucormycosis: Is GRP78 a possible link?
    Gumashta J; Gumashta R
    J Infect Public Health; 2021 Oct; 14(10):1351-1357. PubMed ID: 34538732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucormycosis: An opportunistic pathogen during COVID-19.
    Mahalaxmi I; Jayaramayya K; Venkatesan D; Subramaniam MD; Renu K; Vijayakumar P; Narayanasamy A; Gopalakrishnan AV; Kumar NS; Sivaprakash P; Sambasiva Rao KRS; Vellingiri B
    Environ Res; 2021 Oct; 201():111643. PubMed ID: 34237335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management.
    Yasmin F; Najeeb H; Naeem A; Dapke K; Phadke R; Asghar MS; Shah SMI; De Berardis D; Ullah I
    Diseases; 2021 Sep; 9(4):. PubMed ID: 34698143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 and development of heart failure: mystery and truth.
    Onohuean H; Al-Kuraishy HM; Al-Gareeb AI; Qusti S; Alshammari EM; Batiha GE
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2013-2021. PubMed ID: 34480616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
    Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
    An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value.
    Anand C B; Senthilkumar S; P N; Ibrahim C M; Afroze M KH; M R
    Cureus; 2022 Apr; 14(4):e24013. PubMed ID: 35547446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enlightening role for cytokine storm in coronavirus infection.
    Zhao Z; Wei Y; Tao C
    Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.
    García-Carnero LC; Mora-Montes HM
    J Fungi (Basel); 2022 Apr; 8(5):. PubMed ID: 35628701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
    Kamrul-Hasan AB; Selim S
    Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.